Results 121 to 130 of about 7,093,593 (187)

Why promising ATMPs fail to reach patients: a qualitative stakeholder-informed analysis of cell therapy access in Europe. [PDF]

J Transl Med
Di Mauro G, Pachetti M, Ploner C, De Luca M, Pellegrini G, Gambini E, Moretti M, Sfiligoj A, Yordanov TE, Knezevic M, Sidoti GB, Papa G, Zacchigna S.   +12 more
europepmc   +1 more source

A roadmap for supporting the development of advanced therapy medicinal products in a European framework. [PDF]

Lancet Reg Health Eur
Van Eldere J, Aiuti A, Lluesma SM, Møller BK, Laursen BE, Lebbe C, Piris A, Carmona J, Goldsobel G, Kintscher U, Vandenberghe P, Huys I, Geers B, Benjamin R, Potter V, Bonini C, Ciceri F, Martino G, Debets R, van der Kuy HPHM, Mielke S, Blomberg P, Ellis E, Müller AMS, Worel N, Künkele A.   +25 more
europepmc   +1 more source

The complex price setting and reimbursement of non-industrial advanced therapy medicinal products. [PDF]

Health Econ Rev
Špacírová Z, Rejon-Parrilla JC, Espín J.   +2 more
europepmc   +1 more source

Correction to "Current State-Of-Play of the EU Advanced Therapy Medicinal Product (ATMP) Field, With an Emphasis on Belgian Human Cell and Tissue Products". [PDF]

Wound Repair Regen
europepmc   +1 more source

Thailand's Emerging Role in the Cell and Gene Therapy Revolution: A Review of Progress and Potential. [PDF]

Clin Transl Sci
Viprakasit V, Tulalamba W, Suksangpleng T, Ekwattanakit S.   +3 more
europepmc   +1 more source

Mesenchymal Stromal Cells: From Bench to Bedside and Back. [PDF]

Transfus Med Hemother
Bieback K, Bugert P.
europepmc   +1 more source

Rare disease clinical trials in Italy (2022-May 2026): current trends, future challenges, and the evolving role as reporting member state. [PDF]

Front Pharmacol
De Paola E, Galliccia F, Maione R, Verrelli NM, Dri DA.   +4 more
europepmc   +1 more source

Developing a consensus-based competency framework for hospital pharmacists in the management of advanced therapy medicinal products (ATMPs): a modified delphi study in Macao. [PDF]

BMC Med Educ
Shi J, Hu H, Ung COL.
europepmc   +1 more source

When will bioprinting become a therapy? Translational and regulatory challenges in urogenital tissue engineering and surgery. [PDF]

Front Bioeng Biotechnol
Ruding M, Shajahan AB, Fossum M, Pennisi CP, Lind JU.   +4 more
europepmc   +1 more source

A product control framework for extracellular vesicle therapeutics: Quality attributes, stability, analytical procedures, and biodistribution. [PDF]

Int J Pharm X
Moon H, Jung SH, Bae S, Bae G, Lee A, Na JH, Kim JH, Choi JU, Lee S.   +8 more
europepmc   +1 more source